COMPREHENSIVE METHOD FOR THE DETERMINATION OF ANTIEPILEPTIC DRUGS USING A NOVEL EXTRACTION TECHNIQUE AND A FULLY AUTOMATED GAS CHROMATOGRAPHRAMBECK B; MEIJER JWA.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 1; PP. 99-103; ABS. GER; BIBL. 90 REF.Article

STEREOSPEZIFISCHE HYDRIERUNG VON (R)-ODER (S)-2-AETHYL-4-PHENYLALLENCARBONSAEURE ZU CIS-BZW. TRANS-2-AETHYL-4-PHENYL-3-BUTENSAEURE MIT CLOSTRIDIUM KLUYVERI = HYDROGENATION STEREOSPECIFIQUE D'ACIDE (R)- OU (S)-ETHYL-2 PHENYL-4 BUTADIENE-2,3 OIQUE EN ACIDE ETHYL-2 PHENYL-4 CIS- ET TRANS-BUTENIQUE PAR C.K.RAMBECK B; SIMON H.1974; ANGEW. CHEM.; DTSCH.; DA. 1974; VOL. 86; NO 18; PP. 675-676; BIBL. 4REF.Article

GAS CHROMATOGRAPHIC METHODS FOR THE DETERMINATION OF ANTIEPILEPTIC DRUGS: A SYSTEMATIC REVIEWRAMBECK B; MEIJER JWA.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 4; PP. 385-396; BIBL. 114 REF.Article

SYSTEMATIC METHOD OF DEVELOPMENT IN LIQUID CHROMATOGRAPHY APPLIED TO THE DETERMINATION OF ANTIEPILEPTIC DRUGSRAMBECK B; RIEDMANN M; MEIJER JWA et al.1981; THER. DRUG MONIT.; ISSN 0163-4356; USA; DA. 1981; VOL. 3; NO 4; PP. 377-395; BIBL. 3 REF.Article

NOTWENDIGKEIT EINER INDIVIDUELLEN PHENYTOIN-DOSIERUNG: EINFLUESSE VON DOSIERUNG, PHYSIOLOGISCHEN FAKTOREN UND COMEDIKATION AUF DIE PHENYTHOIN-SERUM KONZENTRATION BEI ERWACHSENIN STATIONAEREN UND AMBULANTEN EPILEPSIE-PATIENTEN = NECESSITE D'UNE POSOLOGIE INDIVIDUELLE POUR LA PHENYTOINE: INFLUENCES DE LA DOSE, DES FACTEURS PHYSIOLOGIQUES ET DES MEDICAMENTS ASSOCIES SUR LA CONCENTRATION SERIQUE DE PHENYTOINE CHEZ DES EPILEPTIQUES ADULTES HOSPITALISES ET AMBULATOIRESMAY T; STENZEL E; RAMBECK B et al.1982; NERVENARZT; ISSN 0028-2804; DEU; DA. 1982; VOL. 53; NO 5; PP. 291-296; BIBL. 21 REF.Article

PHARMAKOLOGISCHE BEEINFLUSSUNG DER PHENOBARBITAL- UND PHENYTOIN-SERUMKONZENTRATION DURCH VALPROAT BEI EPILEPSIE-PATIENTEN = INFLUENCE PHARMACOLOGIQUE DU VALPROATE SUR LA CONCENTRATION SERIQUE DE PHENOBARBITAL ET DE PHENYTOINE CHEZ LES EPILEPTIQUESRAMBECK B; BOENIGK HE; MAY T et al.1979; NERVENARZT; DEU; DA. 1979; VOL. 50; NO 11; PP. 743-746; BIBL. 20 REF.Article

BIOAVAILABILITY OF THREE PHENYTOIN PREPARATIONS IN HEALTHY SUBJECTS AND IN EPILEPTICS.RAMBECK B; BOENIGK HE; STENZEL E et al.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 12; NO 4; PP. 285-290; BIBL. 35 REF.Article

METHSUXIMID IN DER EPILEPSIEBEHANDLUNG. = METHSUCCIMIDE DANS LE TRAITEMENT DE L'EPILEPSIESTENZEL E; BOENIGK HE; RAMBECK B et al.1977; NERVENARZT; DTSCH.; DA. 1977; VOL. 48; NO 7; PP. 377-382; BIBL. 21 REF.Article

Serum concentrations of valproic acid: influence of dose and comedicationMAY, T; RAMBECK, B.Therapeutic drug monitoring. 1985, Vol 7, Num 4, pp 387-390, issn 0163-4356Article

Urinary hydroxyphenytoin/creatinine ratios as an index of compliance in adult epileptic patients on phenytoin therapyRAMBECK, B; MAY, T.Therapeutic drug monitoring. 1984, Vol 6, Num 2, pp 164-172, issn 0163-4356Article

PROPERTIES OF TWO CLOSTRIDIA STRAINS ACTING AS CATALYSTS FOR THE PREPARATIVE STEREOSPECIFIC HYDROGENATION OF 2-ENOIC-ACIDS AND 2-ALKEN-1-OLS WITH HYDROGEN GAS.BALDER J; GUNTHER H; RAMBECK B et al.1978; Z. (HOPPE-SEYLER'S) PHYSIOL. CHEM.; DTSCH.; DA. 1978; VOL. 359; NO 1; PP. 19-27; ABS. ALLEM.; BIBL. 15 REF.Article

Fluctuations of carbamazepine concentrations during the day for two slow-release preparationsMAY, T; RAMBECK, B.Therapeutic drug monitoring. 1989, Vol 11, Num 1, pp 21-24, issn 0163-4356Article

Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedicationMAY, T; RAMBECK, B.Therapeutic drug monitoring. 1990, Vol 12, Num 2, pp 124-128, issn 0163-4356Article

UEBER DASVORKOMMEN EINER REDUKTASE VON DELTA ²-CARBONSAEUREN IN CLOSTRIDIUM KLUYVERI MIT EINER VON DER BUTYRYL-COA-DEHYDROGENASE VERSCHIEDENEN STEREOSPEZIFITAET = MISE EN EVIDENCE D'UNE REDUCTASE DES ACIDES CARBOXYLIQUES EN DELTA ² CHEZ C. K. DONT LA STEREOSPECIFICITE EST DIFFERENTE DE CELLE DE LA BUTYRYL-COA DESHYDROGENASEHASHIMOTO H; RAMBECK B; GUENTHER H et al.1975; Z. (HOPPE-SEYLER'S) PHYSIOL. CHEM.; DTSCH.; DA. 1975; VOL. 356; NO 8; PP. 1203-1208; ABS. ANGL.; BIBL. 20 REF.Article

Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acidMAY, T. W; RAMBECK, B; NOTHBAUM, N et al.European neurology. 1991, Vol 31, Num 1, pp 57-60, issn 0014-3022Article

Simultaneous HPLC determination of vigabatrin and gabapentin in serum with automated pre-injection derivatizationJUERGENS, U. H; MAY, T. W; RAMBECK, B et al.Journal of liquid chromatography & related technologies. 1996, Vol 19, Num 9, pp 1459-1471, issn 1082-6076Article

Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedicationRAMBECK, B; MAY, T; JUERGENS, U et al.Therapeutic drug monitoring. 1987, Vol 9, Num 3, pp 298-303, issn 0163-4356Article

Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication : Results of a retrospective studyMAY, T. W; RAMBECK, B; JÜRGENS, U et al.Therapeutic drug monitoring. 1999, Vol 21, Num 2, pp 175-181, issn 0163-4356Article

Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsyMAY, T; JÜRGENS, U; RAMBECK, B et al.Epilepsy research. 1999, Vol 33, Num 1, pp 57-65, issn 0920-1211Article

Pharmacokinetic interactions of the new antiepileptic drugsRAMBECK, B; SPECHT, U; WOLF, P et al.Clinical pharmacokinetics. 1996, Vol 31, Num 4, pp 309-324, issn 0312-5963Article

Comparison of a GC method and two HPLC methods for the determination of p-hydroxyphenytoin in urineJUERGENS, U; MAY, T; RAMBECK, B et al.Journal of liquid chromatography. 1986, Vol 9, Num 13, pp 2921-2936, issn 0148-3919Article

Postmortem concentrations of phenobarbital, carbamazepine, and its metabolite carbamazepine-10,11-epoxide in different regions of the brain and in the serum : analysis of autoptic specimens from 51 epileptic patientsRAMBECK, B; SCHNABEL, R; MAY, T et al.Therapeutic drug monitoring. 1993, Vol 15, Num 2, pp 91-98, issn 0163-4356Conference Paper

Postmortem concentrations of phenytoin in different regions of the brain and in the serum : analysis of autoptic specimens from 24 epileptic patientsRAMBECK, B; SCHNABEL, R; MAY, T et al.Therapeutic drug monitoring. 1992, Vol 14, Num 1, pp 27-35, issn 0163-4356Article

Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescentsRAMBECK, B; SAÊLKE-TRAUMANN, A; MAY, T et al.European neurology. 1990, Vol 30, Num 2, pp 79-83, issn 0014-3022, 5 p.Article

Comparison of total and free phenytoin serum concentrations measured by high-performance liquid chromatography and standard TDx assay : Implications for the prediction of free standard phenytoin serum concentrationsMAY, T. W; RAMBECK, B; JÜRGES, U et al.Therapeutic drug monitoring. 1998, Vol 20, Num 6, pp 619-623, issn 0163-4356Article